GSK3B and cancer: According to these results, we could infer that TET3 inhibits the phosphorylation level of GSK3β (especially on Ser9 site) through the activated PI3K/AKT signaling pathway, enhancing the stability of β-catenin in cancer cells and subsequently participating in downstream gene transcription related to cell proliferation and metastasis.